China OKs study of Telix PET radiotracer for kidney cancer
Telix Pharmaceuticals has received approval in China for a study of its investigationa...Read more on AuntMinnie.comRelated Reading:
Telix and BAMF use Illuccix for total-body prostate PET
Telix announces new CEO and dose of final patient in ZIRCON study
Telix, Invicro further AI partnership
Telix gets pass-through status for Illuccix
Monrol to supply Telix with Lu-177 for renal cancer trial
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Cancer | Cancer & Oncology | China Health | Kidney Cancer | Partnerships | Radiology | Study | Urology & Nephrology